Statistics
Publications
46
Citations
5.2K
H-Index
27
Active since
1991
Christopher Mohr is an author at Amgen (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.
Publications per year
1991–2025
46
46
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
Jude Canon, Karen Rex, Anne Y. Saiki et al. · Nature · 2019 · 2.3K citations
Medicine, Oncology, Pharmacology +14
1–5 of 46